Navigation Links
Labopharm Reports Results for Second Quarter Fiscal 2009
Date:8/7/2009

>

Research and development expenses, before research and development tax credits, for the second quarter of fiscal 2009 were $3.2 million compared with $7.0 million for the second quarter of fiscal 2008. The decrease was primarily the result of lower clinical trial costs in the second quarter of fiscal 2009. Research and development tax credits for the second quarter of fiscal 2009 were $0.3 million compared with $0.7 million for the second quarter of fiscal 2008, the result of a decrease in non-refundable Canadian federal tax credits due to a change in tax planning.

Selling, general and administrative expenses for the second quarter of fiscal 2009 were $6.3 million compared with $6.2 million for the second quarter of fiscal 2008. A significant portion of selling, general and administrative expenses for the second quarter of fiscal 2009 was the result of higher costs related to sales and marketing and the accrual for the Company's share of litigation costs incurred by Purdue Pharma to enforce certain of Purdue's U.S. patents related to Labopharm's once-daily tramadol product. These were partially offset by lower costs for consultants and professional services, a reduction in non-cash stock-based compensation and a reduction of tax on capital.

Net loss for the second quarter of fiscal 2009 was $4.9 million, or $0.09 per share, compared with $10.3 million, or $0.18 per share, for the second quarter of fiscal 2008. The decrease in net loss was primarily the result of lower research and development costs, higher gross margin on product sales and a higher foreign exchange gain, which were partially offset by lower interest income in the second quarter of fiscal 2009.

Cash, cash equivalents and marketable securities at June 30, 2009 were $27.9 million compared with $35.9 million at March 31, 2009. The cash, cash equivalents and marketable securities position at June 30, 2009 does not include the Company's Long-Term Notes, received in
'/>"/>

SOURCE Labopharm Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Labopharm to present at Canaccord Adams 29th Annual Global Growth Conference
2. Labopharm to host conference call Friday, August 7, 2009 at 8:30 a.m. (ET)
3. Labopharm receives complete response letter from the U.S. FDA for novel antidepressant
4. Labopharm amends debt facility agreement with Hercules
5. Results of phase III study on Labopharms novel antidepressant published in Psychiatry (Edgemont) Journal
6. Labopharm Reports Results for First Quarter Fiscal 2009
7. Labopharm announces details for first quarter results conference call and annual meeting
8. Labopharm reports results for Phase III study on twice-daily tramadol-acetaminophen formulation
9. Labopharm to present at Cowen 29th Annual Health Care Conference
10. Labopharm Reports Results for Year End and Fourth Quarter Fiscal 2008
11. Labopharm to host conference call Thursday, February 26, 2009 at 8:30 a.m. (ET)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... (PRWEB) September 30, 2014 Top10BestSEOHosting.com ... and reviews about hosting products. It is headed ... rich experience. The site offers research-based information and ... and suppliers in the current market. , ... and announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ) and ...
(Date:9/29/2014)... LA (PRWEB) September 29, 2014 ... mission is to provide students with a certification ... awareness necessary to enhance their own lives, and ... Fitness Professionals also benefits the community at large, ... service focused on the professional practice of fitness, ...
(Date:9/29/2014)... September 29, 2014 Each year over ... to complaints of dizziness and imbalance. Symptoms of vestibular ... next and the population range can vary as much ... people will be seeking medical assistance for dizziness and ... from combat with post blast or post concussion injuries ...
(Date:9/29/2014)... Thousand Oaks, Calif. (PRWEB) September 29, 2014 ... and Injury Relief (PMIR) and Thousand Oaks Surgery Center ... Serra Medical Plaza, a state-of-the-art healthcare facility in Thousand ... to these two practices that offer Conejo Valley residents ... patients with acute and chronic pain, while TOSC physicians ...
(Date:9/29/2014)... The specialists from LunaDress always prides themselves on their ... of the price. To benefit more ladies, LunaDress often ... its online store. Today, the company has happily launched ... party dresses . The company’s sales manager says that ... , "We are excited to announce the new ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com: New Reviews for Linux Web Hosting Suppliers Available Online 2Health News:Narconon Louisiana New Life Retreat Announces Stephen Mogavero Now Certified as a Personal Trainer 2Health News:North American Seminars Received PT Continuing Education Course Approval in California and Nevada and Illinois for an Online Vestibular Continuing Education Course 2Health News:New Thousand Oaks Medical Facility Hosts Grand Opening Event: Two Practices, One Celebration 2Health News:New Thousand Oaks Medical Facility Hosts Grand Opening Event: Two Practices, One Celebration 3Health News:At The Beginning Of Autumn, LunaDress Provides Huge Deals On Its Cocktail Party Dresses 2
... Thought-Leader Joins Senior Management Team, NASHVILLE, Tenn., ... of revenue cycle management and clinical communication,solutions, announced ... Senior,Vice President of Corporate Strategy, effective immediately., ... the business of healthcare,and health information technology. Most ...
... 20 Shamir Optical,Industry Ltd. (Nasdaq: SHMR ) ... on Wednesday, May 28, 2008, and has scheduled a,conference ... that morning., The conference call will be broadcast ... to http://www.kcsa.com approximately ten minutes before the,conference ...
... to be widely available for chronic pain sufferers., ... Pharma, Inc.,(Other OTC:INNP.PK - News) is pleased to ... to the Natural Pain Relief Center,non-narcotic proprietary breakthrough ... one in five Americans suffer with chronic pain ...
... to treat patients with latent tuberculosis (TB), who are infected ... less than half the time and at a lower cost ... a multi-center, randomized controlled trial. The results will be presented ... on Tuesday, May 20. , We found that using ...
... 20 /PRNewswire-FirstCall/ - Haemacure Corporation (TSX :,HAE), ... plasma-derived protein products for commercialization,announces that Gilles ... Finance at the Montreal Sheraton Centre on ... Busines$ Meets Finance, Busines$ Meets Finance ...
... Health IT Solutions Recognized, BOSTON, May 20 ... TEPR Awards honorees during the Opening Session of,the ... Conference in,Ft. Lauderdale, Florida., TEPR Awards annually ... and solutions. The 2008 TEPR Awards honorees,are:, ...
Cached Medicine News:Health News:Emdeon Business Services Names Miriam Paramore Senior Vice President of Corporate Strategy 2Health News:Shamir Optical Industry Ltd. to Host Conference Call Announcing First Quarter 2008 Earnings Results 2Health News:Innolife Pharma Inc. acquires rights to breakthrough in non-narcotic chronic pain treatment 2Health News:Rifampin: Latent TB treatment saves time money and lives 2Health News:Haemacure to Present at Busines$ Meets Finance on May 20, 2008 at the Montreal Sheraton Centre 2Health News:2008 TEPR Awards Honorees Announced 2
(Date:9/29/2014)... AMBLER, Pa. , Sept. 29, 2014 /PRNewswire/ ... approval for the CNS Monitor, a medical device ... patients. The CE Mark certifies that a product ... in Europe . ... parameters including electroencephalography (EEG, or brain waves) to ...
(Date:9/29/2014)... , Sept. 29, 2014  Volcano Corporation ... focused on improving patient and economic outcomes on ... minimally invasive coronary and peripheral visualization, physiology diagnostics ... to its Board of Directors from Engaged Capital, ... response:  Volcano welcomes the perspectives ...
(Date:9/29/2014)... NEW YORK , Sept. 29, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "EU5 Sigmoidoscopes Market ... the EU5 Sigmoidoscopes market. The report provides value, ... and average prices (in US dollars) within market ... (Rigid Non-Video Sigmoidoscopes and Flexible Non-Video (Fibre) Sigmoidoscopes). ...
Breaking Medicine Technology:Moberg CNS Monitor Receives European CE Mark Approval for Advanced Neurological Monitoring 2Volcano Issues Statement Regarding Letter From Engaged Capital 2Volcano Issues Statement Regarding Letter From Engaged Capital 3EU5 Sigmoidoscopes Market Outlook to 2020 2EU5 Sigmoidoscopes Market Outlook to 2020 3
... NASHVILLE, Tenn., Aug. 4, 2011 Cumberland Pharmaceuticals Inc. ... has executed a new senior credit agreement with Bank of ... its revolving line of credit to $10 million, which is ... the new facility has been extended to December 2014. ...
... Purdue Pharma, L.P., a privately held pharmaceutical ... International , a U.S.-based humanitarian organization that helps ... view the multimedia assets associated with this release, ... (Photo: http://photos.prnewswire.com/prnh/20110804/MM46982 ) Purdue ...
Cached Medicine Technology:Cumberland Pharmaceuticals Inks New Bank Financing Deal With Bank of America 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 2Purdue Pharmaceuticals Donates Medical Supplies to Protect Poor Children From Infection 3
... Total Knee System provides the adaptability surgeons ... patient. Not the other way around. The ... inserts and patellar components allow surgeons to ... you do it all with one instrument ...
... new implant. It's a new material, exclusively ... can be greatly reduced . The nickel ... of the nickel-sensitive patient. Hardness, lubricity and ... is available in our two already proven ...
... TC-PLUS Solution tricompartmental total knee prosthesis stems ... arthroplasty. State-of-the-art design and manufacturing technologies have ... biomechanical function as well as a favorable ... insert to keep wear to a minimum. ...
Cementless hip system...
Medicine Products: